For the last few years, we’ve heard, “Anti-CD47 is coming, and it’s really going to mess up our testing!” Now it’s here, and we were right! Connie Westhoff explains how we can accurately test our patients’ blood.
You Think DARA was Bad?
Almost since DARA was introduced, there have been rumblings and rumors about a new chemotherapeutic agent, anti-CD47, that would have FAR greater impact on the routine tests performed in blood banks everywhere. Well, anti-CD47 is now in active trials in several places in the U.S., and it looks like our fears have been realized: This drug heavily coats red blood cells, and causes major problems with ABO testing, antibody detection tests, and platelet compatibility tests.
Connie to the Rescue!
Dr. Connie Westhoff and her group from the New York Blood Center report on their experience with a series of four patients on anti-CD47 in the February 2019 journal, “Transfusion” (see link below). Connie is here to share with us what works, what clearly does NOT work (Hello, DTT!), and proactive steps clinicians and blood bankers can take to make things much easier for us and the patients on this medication (Hello, pre-treatment genotyping!).
Our first thing was to try and remove it from the red cells like it works so well for DARA! DTT, enzymes… So we threw the kitchen sink at CD47 and nothing “stuck,” so to speak. DTT doesn’t destroy the epitope, enzymes don’t destroy the epitope, papain, chymotrypsin, ficin; none of those things. W.A.R.M. reagent; nothing will denature the CD47 on the test red cells.
About My Guest:
Connie Westhoff, SBB, PhD is the Executive Scientific Director of the Laboratory for Immunohematology and Genomics at the New York Blood Center and the National Center of Blood Group Genomics in Kansas City. Dr. Westhoff lectures nationally and internationally, and has published more than 100 scientific papers and numerous book chapters. She is an Associate Editor for the Immunohematology and Genomics Section of the AABB journal “Transfusion,” and is also an editor of several editions of the AABB “Technical Manual” (my recommended textbook for those learning Transfusion Medicine). Connie is also an avid supporter of the National Blood Foundation and one of the original inductees to the National Blood Foundation Hall of Fame.
Check out Connie’s previous appearance on the podcast, where she describes how to deal with serologic Weak D with molecular testing.
This podcast episode offers a FREE continuing education activity where you can earn the following types of credit: 1 AMA PRA Category 1 CreditTM, 1 ASCLS P.A.C.E. ® Contact Hour (including Florida Clinical Laboratory Credit), and American Board of Pathology Self-Assessment Modules (SAMs) for Continuing Certification (CC, formerly MOC).
To receive credit and review the accreditation information and related disclosures, please visit Transfusion News Continuing Education on Wiley Health Learning.
DISCLAIMER: The opinions expressed in this episode are those of my guest and I alone. Those opinions do not necessarily reflect those of the organizations with which either of us is affiliated. This podcast does not constitute formal medical advice. Please discuss all medical issues and decisions with your local health care providers. Neither Dr. Westhoff nor I have any relevant financial disclosures.
The images below are generously provided by Dr. Connie Westhoff.